A. Durmuş Et Al. , "THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.," Georgian medical news , no.253, pp.26-9, 2016
Durmuş, A. Et Al. 2016. THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.. Georgian medical news , no.253 , 26-9.
Durmuş, A., YILMAZ, A., MALYA, F. Ü., ÖZTÜRK, G., Bektasoglu, H. K., ertuğrul, g., ... KARYAĞAR, S.(2016). THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.. Georgian medical news , no.253, 26-9.
Durmuş, Ali Et Al. "THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.," Georgian medical news , no.253, 26-9, 2016
Durmuş, Ali Et Al. "THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.." Georgian medical news , no.253, pp.26-9, 2016
Durmuş, A. Et Al. (2016) . "THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.." Georgian medical news , no.253, pp.26-9.
@article{article, author={Ali Durmuş Et Al. }, title={THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.}, journal={Georgian medical news}, year=2016, pages={26-9} }